Indian pharma firms lag behind global peers in RnD, Patents, Publications, reveals report MD Bureau21 Oct 2024 2:15 PM ISTThe largest disparity was observed in the number of publications per billion USD revenue, with global firms producing 8.4 times more publications than...
Biocon gets 4 USFDA observations for Bengaluru facility Ruchika Sharma30 Sept 2024 6:45 PM ISTBangalore: Biocon has announced that the U.S Food and Drug Administration (US FDA) has concluded a surveillance inspection with four...
USFDA concludes inspection at Biocon Biologics Malaysia Insulins facility Ruchika Sharma30 Sept 2024 1:15 PM ISTKarnataka: Biocon Biologics has announced that the US Food and Drug Administration (USFDA) has completed a cGMP inspection at the Company's...
Biocon partners with Tabuk Pharma to commercialize GLP -1 products in Middle East region Ruchika Sharma27 Sept 2024 11:30 AM ISTBengaluru: Biocon Limited, a global biopharmaceutical company, has announced the signing of a licensing and supply agreement with Tabuk...
Biocon Biologics announces New Dermatology data to be presented at EADV Congress 2024 Ruchika Sharma25 Sept 2024 2:48 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd has announced new dermatology data presented at the European Academy of...
USFDA concludes inspection at Biocon Bengaluru API facility Ruchika Sharma23 Sept 2024 12:06 PM ISTBangalore: Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded a surveillance inspection at the Company's...
Kiran Mazumdar-Shaw calls for innovation-driven value creation in India's biotech sector MD Bureau Team13 Sept 2024 3:13 PM ISTNew Delhi: Biocon Chairperson Kiran Mazumdar-Shaw on Thursday called for more investment in research and development to drive innovation and...
Biocon arm gets USFDA nod for chronic heart failure drug Sacubitril/Valsartan Ruchika Sharma2 Sept 2024 11:27 AM ISTBangalore: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval of its...
Biocon gets USFDA EIR for Visakhapatnam API facility Ruchika Sharma6 Aug 2024 11:33 AM ISTBangalore: Biocon has announced that the Company has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated...
USFDA concludes inspection at Biocon Biologics Bengaluru facilities Ruchika Sharma29 July 2024 12:53 PM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) has concluded a combined cGMP inspection and PreLicensing Inspection (PLI) at...
Biocon Biologics plans to raise Rs 4,000-4,500 crore via local bonds: Report Ruchika Sharma8 July 2024 12:30 PM ISTBiocon Biologics Ltd., a biopharmaceutical company, is considering raising between Rs 4,000 crore and Rs 4,500 crore from India’s local-currency bond...
USFDA inspection: Biocon gets 4 observations for Visakhapatnam API facility Ruchika Sharma24 Jun 2024 2:15 PM ISTBangalore: Biocon has informed in a BSE filing that the U.S. Food and Drug Administration (USFDA) has concluded a GMP inspection of the...
